Global MedTech Giants Unveil Premier Innovations at CIIE: Medtronic, Johnson & Johnson Lead with Breakthrough Launches
Medtronic
Medical Device Manufacturer
Source:Medical Device Business Review
The 7th China International Import Expo (CIIE) grandly opened in Shanghai, a leading global event for medical technology and innovation trends, once again capturing worldwide attention.
The Leading Enterprise in the Global Medical Device Industry——Including the top ten industry giants led by Medtronic, all have brought"Global Debut" and "Asian Premiere"etc.Blockbuster Product Makes Its Debut.
Exhibits of This TimeSpanning key medical fields such as cardiovascular, orthopedics, neuroscience, oncology, ophthalmology, and dentistryFrom precision medicine to AI-assisted diagnostics, from telemedicine technology to wearable health monitoring devices, the exhibition comprehensively covers the cutting-edge developments in current medical technology, showcasing how future medical services will better adapt to and meet the needs and expectations of the Chinese and Asian markets under the trend of localization.，ForInject New Vitality into the Healthcare Industry in China and Asia
Medical Device Business Review Hits the Scene of This CIIE，Witness andRecordThisA Cutting-Edge Medical Feast of Global Wisdom and Local Innovation。
Medtronic
As a "regular participant" of the CIIE, Medtronic has attended the exhibition for seven consecutive years, bringing a total of 400 products and 60 first-shows to China.This year marks the anniversary of MedtronicGlobal 75th Anniversary, and at the same time, it is also the companyThe 35th Year of Investing in China。At this CIIE, Medtronic focuses on "new quality productivity in healthcare" and once again brings7 debut products, nearly 100 heavyweight innovative exhibitsDebut Conference.
The exhibits launched by Medtronic this time includeWorld PremiereThe Evolut FX+ Transcatheter Aortic Valve System,Asia-Pacific PremiereThe VitalFlow ECMO SystemPenditure Left Atrial Appendage Closure System, Percept™ RC Rechargeable Deep Brain Stimulator, SynchroMed™ III Implantable Drug Infusion Pump, as well as the China debut of Nitron CryoConsole™ Cryoablation System and Tri-Ad™ 2.0 Tricuspid Annuloplasty Ring, covering three major business areas: cardiovascular, neuroscience, and medical surgery.
The appearance of several groundbreaking innovative exhibits also made the Medtronic booth one of the liveliest exhibition areas. The booth was crowded with people. As multiple significant exhibits were presented and introduced, the atmosphere at the exhibition remained heated, with lively exchanges, attracting industry professionals from all over China to stop by.
Swipe left or right to view more
First Look at New Products
Global Premiere: Evolut FX+ Transcatheter Aortic Valve Replacement (TAVR) System
Medtronic has brought the latest generation Evolut FX+ Transcatheter Aortic Valve Replacement (TAVR) System, which is also the Evolut FX+ inFor the First Time GloballyPublic display to the public. Applicable to patients with severe symptomatic aortic stenosis across all risk categories (extreme, high, moderate, and low).
Compared with traditional open-chest surgery, this system has the advantages of no need for open-chest surgery, minimal trauma, short hospital stay, and quick postoperative recovery. Compared with the previous generation product, Evolut FX+ has optimized the stent design.Reserves more space for future coronary intervention catheter operations.At the same time,According to Medtronic's Q4 financial report for the fiscal year 2024: Due to the continued adoption of the Evolut FX Transcatheter Aortic Valve Replacement (TAVR) system, the companyStructural heart disease business achieved double-digit growth in Western Europe and Japan.
Medtronic's Latest Generation Evolut FX+ Transcatheter Aortic Valve Replacement (TAVR) System
Asia-Pacific Debut: VitalFlow ECMO System, Percept™ RC Rechargeable Deep Brain Stimulator, Penditure Left Atrial Appendage Closure System
VitalFlow ECMO System, is a recently launched configurable single-system ECMO system by Medtronic, bridging the gap between bedside care and in-hospital transport. It provides doctors and clinicians with a more relaxed, portable, and intelligent ECMO experience, reflecting Medtronic's commitment to developing life-saving technologies.Cardiopulmonary Medical DevicesThe determination to address the clinical needs of acute and chronic cardiopulmonary diseases.
Medtronic VitalFlow ECMO System
Percept™RC，YesThe World's FirstPerceptible and Rechargeable Deep Brain Neurostimulator, Thanks to advanced battery technology, this product can maintain over 99% of its battery capacity for more than a decade after being implanted in the human body, significantly reducing...Reducing reliance on manual adjustments provides patients with a more precise and convenient treatment experience.
Medtronic Percept™ RC Rechargeable Deep Brain Stimulator
Penditure Left Atrial AppendageClosed System，It is an innovative implantable clip that uses physical means to compress and occlude the left atrial appendage, designed to assist in the management of the left atrial appendage (LAAM) during cardiac surgery.Currently the only product that can be retrieved and redeployed during surgeryThe left atrial appendage clamp allows doctors to better adapt to changes during the surgical process.
Medtronic Penditure Left Atrial Appendage Closure System
Thanks to the CIIE platform, Medtronic has accelerated the introduction and implementation of many globally leading innovative medical technologies and solutions through the launch of several innovative products, better meeting the diverse and high-quality healthcare needs of local patients.
Johnson & Johnson Medical Technologies
2024 is a brand renewal year for Johnson & Johnson Medical Technology. This year's CIIE,Walking into the Johnson & Johnson booth, the first thing that catches your eye is a striking shade of red,This is also the brilliance of many innovative products.
This Year's CIIEJohnson & Johnson Medical Technologies presents more than a hundred innovative products, including over 20 products making their China debut.Including the MONARCH® digital surgical robot for bronchoscopic diagnosis and treatment of lung cancer, and the innovative paddle-shaped design of the single-use magnetic positioning mapping catheter.OPTRELL™, the first high-frequency surgical device Megadyne, the new generation of antibacterial Vicryl® laparoscopic port needles, etc.
Digital Surgical Robot MONARCH® for Bronchoscopic Diagnosis and Treatment of Lung Cancer
First Look at New Products
In the field of cardiovascular and cerebrovascular diseases, Johnson & Johnson bringsFour Exhibits Making Their Debut in China and Globally，Including:
China Launch: OPTRELL™ Single-Use Magnetic Mapping Catheter
Innovative Paddle Design Disposable Magnetic Positioning Mapping Catheter OPTRELL™ Makes China Debut at CIIE，The product was approved for marketing by the NMPA in September this year. As a multi-electrode magnetic positioning mapping catheter, this product features real-time activation vector arrow indication and TRUEref™ noise reduction technology, making it...Currently, the most advanced paddle-type mapping catheter approved by NMPA.
OPTRELL™ Single-Use Magnetic Localization Mapping Catheter
China Debut: Impella CP with SmartAssist Interventional Left Ventricular Assist Pump
In addition, Johnson & Johnson has also brought advancements in the field of heart failure treatment.Heavyweight Innovative Product: Impella CP with SmartAssist Interventional Left Ventricular Assist PumpDebuted in China. It is reported that the Impella series was innovatively launched by Abiomed, a leader in the artificial heart field. In 2022, Johnson & Johnson acquired Abiomed for $16.6 billion. With Johnson & Johnson's support, the Impella products, which were already bestsellers overseas, gained even more momentum.Johnson & Johnson has pushed for the Impella product to enter China's medical device innovation channel in October 2024.The exhibition at the CIIE will leverage the spillover effects of the CIIE to accelerate product approvals.
Impella CP with SmartAssist Interventional Left Ventricular Assist Pump
China Launch: Next-Generation Monofilament Non-Absorbable Suture Pronova®
Johnson & JohnsonThe new generation of monofilament non-absorbable sutures, Pronova®, made its China debut at this year's CIIE.Applied in minimally invasive cardiovascular surgeries, its characteristics of tighter knot formation, softness without tangling, and strong resistance to damage have brought convenience to myocardial soft tissue suturing and vascular anastomosis during operations.
A New Generation of Monofilament Non-Absorbable Sutures, Pronova®
Global Launch: Multi-Electrode Hollow Catheter STSF
Multi-Electrode Cavity Catheter STSF with Intelligent Precision Pressure Indication and Multi-Hole Perfusion TechnologyNot only is it the world's first release, but also Johnson & Johnson Medical Technologies' first locally produced pressure ablation catheter in China, showcasing the latest achievement of deep integration between Chinese innovation and Johnson & Johnson's global resources.
Localization of New Products: The New Generation of Antibacterial Vicryl® Laparoscopic Suture Needles and Matrix ORTHOGNATHIC LOCK™ System
Among the many high-tech products displayed by Johnson & Johnson Medical Technology at this year's CIIE, we can see more.China, locally produced 'China Intelligent Manufacturing' innovative products,For exampleNew Generation Antibacterial Vicryl®Laparoscopic port needles are researched and developed in China and manufactured in China.Suture with a flattened designCan more effectively improve the surgeon's needle-holding experience and address the pain points encountered by surgeons when suturing muscle and fascia layers at the trocar site.Matrix ORTHOGNATHIC LOCK™ System: A Fixed Orthognathic Correction System Specifically Designed for Asian PopulationsProviding doctors with more options, a longer osteotomy distance, and a more stable fixation effect.
New Generation Antibacterial Vicryl® Laparoscopic Suture Needle
Roche Diagnostics
As one of the earliest multinational companies to support and participate in the CIIE, Roche this year"Brilliant Thirty, Gathering the Future"With the theme of, fully showcase over [...] on the 1,000-square-meter CIIE booth.30 Products Already LaunchedAndThe Full Product Matrix and Innovative Solutions to be Launched in China, and launched three global innovative products that are about to be approved in China.
In addition, Roche's future pipeline in China also made its debut at the CIIE stage, with a focus on the COPD field.World's FirstThe fully humanized anti-ST2 monoclonal antibody Astegolimab.
Interestingly, in addition to more than 30 blockbuster products, Roche's booth also features several fun interactive check-in areas: an early lung medical device, the "Intelligent Healing Photo Studio," and a Vision Pro device simulating surgical scenes, attracting visitors to experience them personally.Experience "Black Technology" from Roche。
First Look at New Products
China's First: cobas pure Next-Generation Biochemistry and Immunoassay System
This exhibition launchedChina's FirstRoche Diagnostics' New China-Produced Product, the All-New Generation Biochemical Immune Analysis System cobas pure, Which Continues the Core Advantages of Roche's cobas Family,Integrating multiple latest "black technologies",Break through the limitations of time, space, etc.`, which can minimize manual operation to the greatest extent and meet the needs of different types of experiments.`
Facing the continuous growth of testing demands, laboratories are under tremendous pressure. As a brand-new compact analyzer, the cobas pure integrated solution occupies only 2 square meters, reducing the footprint by 30% compared to the previous generation system, andCovering nearly 200 biochemical and immunoassay tests. Capable of performing up to 870 tests per hour, helping small and medium-sized laboratories make better use of space and expand their menu of high medical value tests.
cobas pure Next-Generation Biochemistry and Immunoassay System
Blockbuster New Product: LightCycler® PRO System Coming Soon!
This timeDebut at the ExhibitionThe LightCycler® PRO System Real-Time PCR Instrument, which has not yet been launched, is the latest member of Roche's LightCycler Real-Time PCR series and alsoSignificant improvements and upgrades based on the previous generation product, aiming to become the most advanced qPCR technology in clinical diagnosis and research.
This system raises the bar for performance and usability and is expected to serve customers in research and clinical fields, as well as those looking to convert Research Use Only (RUO) assays into In Vitro Diagnostic (IVD) tests, bridging the gap between RUO and IVD.
LightCycler® PRO System Real-Time Fluorescence Quantitative PCR Instrument
China's First: Fully Automatic Immunohistochemistry Staining Platform
At this year's CIIE, Roche Diagnostics officially announced the launch of the fully automated immunohistochemistry staining platform, BenchMark ULTRA PLUS. It is reported that this product...China-produced Pathology Diagnostic Platform Officially Put into Production at Roche Diagnostics Asia-Pacific Production Base and R&D Center.
As the "gold standard" for disease diagnosis, the significant value of accurate and efficient pathological diagnosis in the era of precision medicine is becoming increasingly prominent. Since its launch in China in 2022, BenchMark ULTRA PLUS has brought a comprehensive革新 upgrade to pathological diagnosis.
Two years later, BenchMark ULTRA PLUS has successfully achieved localized production in China, becomingThe First Pathology Diagnostic Product of "Made in China"This is another strong proof of Roche Diagnostics' rapid response to the high-quality development needs of pathology laboratories in China and its empowerment of precision diagnosis and treatment.
Fully Automatic Immunohistochemistry Staining Platform BenchMark ULTRA PLUS
Siemens Healthineers
This year, Siemens Healthineers"Local Wisdom, Global Collaboration"Themed, Seven Participations in the CIIE, Heavyweight Display of Nearly20 ModelsInnovative medical technologies and solutions, nearly10 Products Are New Releases and Exhibitions, which not only demonstrates Siemens Healthineers' business philosophy of innovation-driven development, but also highlights its confidence and determination to meet the health needs of the people and serve the high-quality development of China's healthcare industry.
At the CIIE, Siemens also unveiled its AI Innovation Lab Platform for the first time. The platform will leverage Siemens Healthineers' global digital technology R&D capabilities andChina-based AI R&D Scientist TeamRelying on this, help more users transform clinical needs into products, and encourage local companies to carry out joint innovation.
And further expand the ecological landscape during the exhibition by releasing multiple jointly created solutions,Sign Agreements with Multiple Chinese Enterprises and Hospitals to Deepen Cooperation, such as Siemens successfully holding a signing ceremony with Jiangxi Provincial People's Hospital on site, etc.
Signing Ceremony Venue
<Swipe left or right to view more>
First Look at New Products
World's First: "Dual Ultra-High Field" Top Research MRI Platform
At this year's CIIE, Siemens重磅发布The world's first "dual ultra-high field" top scientific research MRI platform.The platform consists of the 7T ultra-high field strength magnetic resonance MAGNETOM Terra.X and the ultra-high gradient field strength magnetic resonance MAGNETOM Cima.X, which can provideSystemic Tumors, Neurological, CardiacProvide new imaging biomarkers for a wide range of diseases in fields such as ... . In addition, these two devices can achieve seamless transplantation of scanning sequences and precise comparison of lesion characteristics, offering stronger support for clinical diagnosis and scientific research.
Siemens 7Ultra-High Field MRI MAGNETOM Terra.X
At the same time, MAGNETOM Terra.X is alsoChina's First Approved Next-Generation 7T MRI.It is the first to break the boundary of ultra-high field MRI with single hydrogen nucleus imaging, and its gradient performance is four to five times higher than that of traditional 3T MRI. Its micrometer-level high-resolution imaging capability can capture and reproduce microscopic details of tissue structures, providing solid data support for early disease screening and the development of precision medical plans, marking another significant milestone in personalized diagnosis and treatment.
Siemens 7T Ultra-High Field MRI MAGNETOM Terra.X
World's First: Full-Body Spatiotemporal Sensing PET/CT
At the exhibition site, Siemens also launchedWorld's First Full-Body Spatiotemporal Sensing PET/CT Biograph Vision Quadra Aurora 2.0, which is also the first launch and exhibition of this device in Asia.
According to Wang Tao, Vice President of Siemens Healthineers Greater China and head of marketing and corporate communications, the radiation level of this device is extremely low, only 1/50 that of a conventional PET/CT, allowing sensitive populations such as newborns and pregnant women to undergo PET/CT scans. Additionally, the device is also very friendly to diabetic patients, who can undergo the examination without prolonged blood sugar control, without affecting the accuracy of the results.
Siemens Whole-Body Temporal Sensing PET/CT Biograph Vision Quadra Aurora 2.0
World's First: DSA-OCT Integrated Multimodal Diagnosis and Treatment Platform
In the field of coronary heart disease treatment, Siemens Healthineers has partnered with China's local enterprise MicroLight Medical to jointly launchWorld's First DSA-OCT Integrated Multimodal Diagnosis and Treatment Platform vivolight®Integrated, and made its "global debut" at the CIIE.
This integrated cardiovascular multimodal diagnosis and treatment solution ingeniously combines DSA (Digital Subtraction Angiography) and OCT (Optical Coherence Tomography) technologies into a single machine. This innovative design can simultaneously display the external shape of blood vessels and internal plaque conditions, providing doctors with more intuitive and accurate diagnostic information, significantly reducing the reliance on doctors' experience.
Siemens DSA-OCT Integrated Multimodal Diagnosis and Treatment Platform
Facing the Medtronic booth is GE Healthcare,A touch of sky blue and a hint of mysterious purple, making Hall 7.1 even more dazzling.
GE Healthcare
As a "full-attendance participant" in seven consecutive CIIEs, GE Healthcare has become a "regular guest" at the CIIE. This not only fully demonstrates and elevates the global chapter of GE Healthcare's story in China, but also strikes a strong note of the times for the integration and coexistence of healthcare between China and the world.
This year, GE Healthcare"Creating Boundless Healthcare Compassion"Themed, aroundComprehensive Solutions for Critical Illness Diagnosis, Grassroots Care, Maternal and Child Care, Integrated Diagnosis and Treatment, Digital Innovation, Smart Services, and Equipment Upgradesetc., exhibitedThe industry's first "micro-brain imaging" magnetic resonance SIGNA Magnus, molecular imaging equipment MAX Apollo AI PET/CT, intraoperative visualization and guidance system bkActiv, obstetrics and gynecology ultrasound Voluson Signature 20, etc.More than 30 typesProducts and technology applications that integrate global wisdom with Chinese innovation, including7 Global Premieres and 10 China Premieres of Cutting-Edge Products, a record high for GE Healthcare's participation in the CIIE!
First Look at New Products
Global FirstExhibition: MAX Apollo AI PET/CT
MAX Apollo AI PET/CT is currentlyGE Healthcare's Latest and Most Advanced Global Nuclear Medicine Molecular Imaging PET/CT, achieving the highest unit sensitivity and spatial resolution in the industry (with image quality that is clearer and more precise). Not only can it perform a full-body scan in 3 minutes, but it can also help doctors accurately differentiate the benign or malignant nature of smaller lesions at an earlier stage.
GE Healthcare MAX Apollo AI PET/CT
Based on MAX Apollo AI PET/CT, GE Healthcare has launchedComprehensive Ecosystem Solution Capability for Early Detection and Precision Diagnosis and Treatment of Alzheimer's Disease (AD), and Major Neurodegenerative Diseases，Possible to detect/diagnose Alzheimer's disease 10-15 years earlier`, bringing a breakthrough integrated innovation solution to address the challenges of accelerating aging and rising AD incidence in China's medical industry.`
World Premiere: Seno Crystal Nova AI
In addition, for breast disease screening and diagnosis, GE Healthcare showcased the digital mammography mobile solution — Seno Crystal Nova AI, which mounts AI mammography on wheels, breaking the location constraints of breast screening.Achieve a leap from convenient operation to intelligent operation, greatly improving the screening efficiency and precise diagnostic capability of breast diseases.
GE Healthcare Seno Crystal Nova AI
Seno Crystal Nova AI is suitable for physical examination and screening work in large factories and enterprises, county-level medical consortia, and remote areas.This will strongly promote the implementation of China's two-cancer (breast cancer and cervical cancer) screening programs.
China's First Exhibition:SIGNA Pilot Lingyun 3.0T "Read-Seconds Imaging" MRI
GE Healthcare also exhibitedLaunched in China this AugustThe SIGNA Pilot Lingyun 3.0T "Scan-in-Seconds" MRI, equipped with GE Healthcare's latest deep learning reconstruction technology AIR Recon DL, can achieve a signal-to-noise ratio efficiency of 6T at 3T field strength, completing a high-definition scan in just one second.Able to shorten the abdominal dynamic enhanced scan from the traditional 20 minutes to 8 minutes, accelerating the process by 2.5 times, achieving high-quality imaging of 100 parts in one day.SIGNA Pilot, paired with SIGNA MAGNUS, will comprehensively enhance the hospital's efficiency and capabilities in precision diagnosis and treatment within the field of severe diseases.
GE Healthcare SIGNA Pilot Lingyun 3.0T
China's First Exhibition: SIGNA Magnus "Microbrain Imaging" MRI
SIGNA MagnusIt is the first "micro-brain imaging" MRI in the industry,Specifically applied to brain and nervous system examinations, its gradient performance is four times that of traditional whole-body MRI, enabling brain imaging to break through to the micron level. It has better detection capabilities for fine brain microstructures and lesions, effectivelyImprove the clinical diagnosis and brain science research level of diseases such as concussion, brain tumor, depression, and Alzheimer's disease.。
GE Healthcare SIGNA Magnus "Microbrain Imaging" MRI
Stryker
This year, Stryker attended the CIIE for the fourth time with the theme of "New Quality Innovation, Building a Healthy Future Together."
Stryker has set up 6 major exhibition areas, focusing on displayingJoints and Mako robots, endoscopes, power tools, trauma, neurointervention, and emergency medical fieldsNearly 40 Cutting-edge Innovative Technologies and Products`, including the Mako SmartRobotics Total Hip Arthroplasty (THA) 4.0 System and the DM Dual Mobility Total Hip System`Six innovative products that made their debut to the public for the first time at the CIIE, as well as two latest products that have been successfully commercialized, transforming "exhibits into goods."。
First Look at New Products
China's First Exhibition: Mako Smart Robotic Total Hip Arthroplasty (THA) 4.0 System
The Mako Smart Robotic System for joint surgery has been on the global market for 18 years, completing over 2 million surgeries, and covering "three-procedure" solutions including total hip, total knee, and unicompartmental knee replacement.It is the only surgical robot on the market that supports triple-joint procedures.
Mako Smart Robotic-Arm Total Hip Arthroplasty (THA) 4.0 System
The Mako SmartRobotics™ Total Hip Arthroplasty (THA) 4.0 system, showcased this time, has added "Functional Preoperative Planning for Hip Surgery" and "Dynamic Impingement Simulation" features. These can assist doctors in planning the implant angle of prostheses preoperatively, simulating postoperative joint function, and performing femoral neck osteotomy navigation during surgery, significantly enhancing the user experience for doctors and improving the precision and stability of hip surgeries.
China Debut: Innovative Emergency Product Stair-Pro Stair Stretcher
In emergency rescueIn the equipment field, Stryker brought its popular star exhibit in the pre-hospital emergency care sector to this exhibition —Stair-Pro Stair Stretcher. As an innovative medical emergency device, this product is specifically designed for the safe transfer of patients in complex environments such as staircases.
Stryker Stair-Pro Stair Stretcher & lsoTour Anti-Decubitus Turning Mattress
The product adopts StrykerPatented Technology Stair-TREAD, equipped with a high-tech battery-driven hydraulic system and a lightweight, reliable X-shaped structural design, which stably supports the overall lifting of the patient transport stretcher, allowing paramedics to avoid exerting force to pull the stretcher upward when transporting patients downstairs, thusReduced the labor intensity and potential risks during the transfer process.
Besides, another highlight of this stretcher is that it is paired with Stryker.China's First Exhibition of lsoTour Anti-Decubitus Turning Mattress, which is made of biomedical-grade silicone material, features a honeycomb structure design combined with "microclimate management" to provide comfort and support for patients who are bedridden for long periods.Effectively prevent the occurrence of bedsores.
China Premiere: MDM Dual-Motion Total Hip System
In the field of orthopedics, Stryker also brought its China-first product to debut at the CIIE ——MDM Dual-Mobility Total Hip System. As an advanced medical implant, this productCharacterized by good stability and a reduced risk of dislocation, it is an excellent choice for hip replacement surgery.
Stryker MDM Dual Mobility Total Hip System
Through Stryker's exclusive optimized design, the MDM system canEnoughEffectively Reduce the Incidence of Hip Dislocation After Surgery, which is of great significance for improving the quality of life of patients and reducing postoperative complications, while providing good stability, which helps to reduceRisk of Hip Dislocation After Surgery.
The MDM Dual-Mobility Total Hip System, one of the latest technological achievements in Stryker's orthopedic device field, demonstrates the company's professional expertise and innovative strength in joint replacement.
China's First Exhibition: SPY PHI Open Fluorescence Imaging System
SPY PHI Open Fluorescence Imaging System isStryker's Latest Frontier System in Fluorescence Technology, combined with the PINPOINT system, can utilize precise fluorescence technology for multi-specialty surgical information assessment in open procedures.Provide professional and truth-seeking clinical judgment basis for clinicians。
Stryker SPY PHI Open Fluorescence Imaging System
Philips Healthcare
As yet another company that has consecutivelyA company that has participated in the exhibition for seven years, this session of the CIIE Philips appeared with a refreshed brand image and released a new Chinese brand slogan——"Innovating with Heart, Caring for All"`, emphasizing the company's commitment to enabling more people to timely access high-quality care through meaningful innovation.`
At this year's CIIE, in terms of professional healthcare, Philips continues to gather cutting-edge technologies from around the globe along with local innovative expertise, presenting its industry-leading lineup of professional medical products, among which...Including multiple first-release and first-exhibition products and solutions, such asMR 7700 Magnetic Resonance Imaging Equipment, CT 5300 High-end CT Scanner, Mobile Ultrasound Systems Xiantong 5500 and Shengtong 5300, Patient Monitoring Virtual Patient Avatar, and other cutting-edge products.Product.
Swipe left or right to view more
Get a Sneak Peek of the New Product
China Premiere: Full-domain* Intelligent MRI Elition AI+
At this year's CIIE, Philips showcased the Elition AI+ fully intelligent MRI, equipped with the internationally exclusive targeted AI technology SmartSpeed and the fully intelligent imaging platform SmartStation.Enabling a new possibility of balancing quality and speed, leading the new era of full-process AI magnetic resonance.
Philips OmniSmart MRI Elition AI+
It is reported that the full-domain intelligent magnetic resonance Elition AI+ canAchieve up to 64x acceleration and 3x throughput improvementMoreover, image details comparable to 7T can clearly reveal the "blind spots" of traditional 3T, enabling precise identification of disease diagnostic targets.
Debut at CIIE: Mobile Ultrasound Systems Preton 5500 and Sounton 5300
Precedent 5500 and Harmonia 5300 arePhilips' Latest Achievements in Advancing Localization, which was approved for marketing in China this July.
Philips Pioneering Vision 5500 and Sound Vision 5300
Both devices are equipped with advanced PureWave probe technology and can be widely applied.Cardiac, vascular, abdominal, superficial tissues, musculoskeletal system, ophthalmology, gynecology, obstetrics, and urology, etc.Clinical examinations and diagnoses in multiple fields to further meetThe application of ultrasound in various clinical scenarios such as bedside, emergency, anesthesia, and critical care.
At the same time, both are equipped with the new TianTong platform and artificial intelligence algorithms.Significantly improved image resolution and detail display capability, providing doctors with clearer and more accurate diagnostic basis, assisting clinicians in rapid and precise diagnosis and treatment.
China's First Release: MR 7700 Magnetic Resonance Imaging Equipment
The MR 7700 MRI equipment exhibited by Philips isThe only one in the world to obtain dual certifications from the European Union's CE (Conformité Européenne) and the U.S. FDA (Food and Drug Administration)The full-body multinuclear magnetic resonance equipment, whose biggest highlight lies in supporting multinuclear imaging, has now expanded to six types of nuclei.Achieve the acquisition of more metabolic and functional information.
Philips MR 7700 Magnetic Resonance Imaging Equipment
At the same time, MR 7700 also hasAdvantages of high precision, high power, and durability, can provide reliable diagnostic support for each patient,It is the preferred system for high-quality diffusion imaging and advanced neuroscience.Philips stated that the XP gradient coil of the MR 7700 systemSignal-to-noise ratio increased by 35%, and scan time reduced by 35%.In addition, the fMRI volume of radiologists increased by 20%, and the number of diffusion tensor imaging (DTI) directions increased by 50%.
In addition, Philips alsoReleased the 2024 China version of the "Future Health Index Report" on the same topic, which started in 2016, the inaugural year of "Philips HealthTech," this is the ninth year of its release, gradually evolving into one of the largest and most influential reports of its kind globally.
Dialogue Interpretation: Future Health Index Report
Abbott
This year marks the fifth year of Abbott's participation in the CIIE, and once again, Abbott has appeared with the theme of "A Galaxy of Technology, Infinite Health," showcasing comprehensively.Diagnosis, Medical Devices, Nutritional Products, and PharmaceuticalsInnovative frontier technology power in core business fields such as...
In the medical device and healthcare exhibition area, Abbott launched dozens of new products for the first time, among which the most significant one is undoubtedlyWorld's First Dual-Chamber Leadless Pacing System AVEIR™ DR, Freestyle Libre 2 Continuous Glucose Monitoring Systemand the fully magnetically levitated artificial heart HeartMate 3™。
First Look at New Products
World's First: Dual-Chamber Leadless Pacing System AVEIR™ DR
As the pioneer of implantable pacemakers, Abbott is committed to bringing significant innovations with medical value to the industry and advancing the treatment of heart diseases. Since 2022, Abbott’s AVEIR™ VR single-chamber leadless pacemaker, designed for treating bradycardia, has embarked on an exciting "journey in China" through the "gateway of the China International Import Expo (CIIE)."This product has been successfully approved for marketing in China this year and the first batch of implant surgeries have been completed.
Abbott Dual-Chamber Leadless Pacing System AVEIR™ DR
AVEIR™ DR isWorld's First Truly Synchronized Dual-Chamber Wireless Pacemaker, which has currently been approved by the FDA and CE certificationThrough Abbott's unique i2i™ communication technology, it enables interconnection and communication between two devices in the right atrium and right ventricle, achieving synchronized and coordinated cardiac pacing with two leadless pacemakers.
China Launch: FreeStyle Libre 2 Continuous Glucose Monitoring System
As a leader in the field of blood glucose monitoring, since its debut at the CIIE in 2020, Abbott has launched a new blood glucose management tool at each event. This year's launch has also arrived as promised.
Abbott FreeStyle Libre 2 Continuous Glucose Monitoring System
The FreeStyle Libre 2 Continuous Glucose Monitoring System is Abbott'sChina Premiere Products at This Year's CIIE, is a globally leading new generation continuous glucose monitoring system.
With this product, users can avoid fingertip blood sampling and rely on sensors and a mobile application.Real-time glucose level monitoring facilitates daily blood sugar management for diabetic patients.The new products launched this year also feature added Bluetooth transmission and optional high/low blood glucose alarms, which alert users when glucose levels are too high or too low, ensuring accurate and stable monitoring for better blood glucose health.
World's First:Implantable Left Ventricular Assist Device HeartMate 3™
HeartMate 3™ was approved for NMPA listing in July this year.The world's first approved and currently the only left ventricular assist system to simultaneously receive the three major authoritative certifications: NMPA, CE, and FDA.
Abbott Implantable Left Ventricular Assist Device HeartMate 3™
HeartMate 3™ is the first to introduce the exclusive Full MagLev™ fully magnetic levitation flow technology, which processes blood through a fully sintered titanium surface.Reduced the risk of blood damage and complications。At the same time, compared with traditional bearing-supported blood pumps, magnetic levitation technology also eliminates mechanical wear, extends the service life of the device, and significantly reduces the occurrence of thrombosis and stroke within the pump.
Based on the data from large-scale 5-year clinical trials,HeartMate 3 can extend the survival period by at least 5 years for patients with advanced heart failure.
Boston Scientific
Boston Scientific, with the theme "Innovating for Life, Advancing Together", showcased technologies that integrate knowledge from interdisciplinary fields such as artificial intelligence, big data, and new materials.More than 80 cutting-edge medical innovation products, coveringCardiac, peripheral vascular, oncology, urology, gastrointestinal, neuromodulation and other fields.
With its exquisite booth design and highly innovative exhibits, Boston Scientific's booth attracted a steady stream of visitors. The staff greeted them with great enthusiasm and immense patience.Provided detailed product introductions and meticulous operation guidance for every visitor., ensuring every visitor enjoys a warm and welcoming experience.
Swipe left or right to view more
First Look at New Products
China Launch: Next-Generation Intravascular Ultrasound System AVVIGO+ MAH
The New Generation Intravascular Ultrasound System AVVIGO+ MAH isThe Latest Representative of Boston Scientific's Local Production and Research in China, with deep involvement of a Chinese team in the R&D of software and hardware, and the core host produced in China, will hold a pre-launch release at this CIIE.
Boston Scientific Intravascular Ultrasound System AVVIGO+ MAH
This device adopts a new chip and is equipped with an AI system that supports vascular assessment functions, while integrating Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (DFR) measurements.Can optimize the evaluation process for doctors in percutaneous coronary intervention (PCI) treatment, shorten operation time, and improve long-term patient outcomes.
World's First: APOLLO ESG Endoscopic Sleeve Gastroplasty System
At the last CIIE, Boston Scientific attracted considerable attention with its weight-loss product, the "intragastric balloon." This year, Boston Scientific has brought another popular weight-loss product — the Apollo ESG Endoscopic Sleeve Gastroplasty System.
This productIs the world's first and currently only endoscopic sleeve gastroplasty system approved by the U.S. FDA., the stomach volume can be reduced by approximately 70%-80% through endoscopic sleeve gastroplasty, which induces early satiety and delays gastric emptying.Help adult patients with obesity and a BMI of 30-50 kg/㎡ who cannot adopt more conservative measures to lose weight or maintain weight loss.
Boston Scientific APOLLO ESG Endoscopic Sleeve Gastroplasty System
It is worth mentioning that, although the Apollo ESG endoscopic sleeve gastroplasty system has not yet been approved for marketing in China,But it has already been used in the Boao Leaping Forward Pilot Zone in Hainan., and it is believed that in the near future, this kind of non-invasive and reversible weight loss treatment will provide more options for clinical weight loss patients.
Fourth-generation DBS product: Vercise Genus
At this CIIE, Boston ScientificFirst-Ever Neuromodulation Exhibition Area Established, showcasing innovative medical solutions for managing chronic pain and treating Parkinson's disease. These includeThe fourth-generation DBS product, Vercise Genus, which was just approved for marketing in China last month.
Boston Scientific Vercise Genus DBS
Vercise Genus DBS features a directional lead electrode design combined with the unique MICC (Multiple Independent Current Control) technology, enabling precise stimulation of target areas while avoiding side effect regions.Alleviate Parkinson's disease symptoms and improve patients' motor function.At the same time, the use of a visual programming system can help doctors "see" the patient's brain structure during the programming process.Reduce programming time.
Only in China: JETSTREAM Atherectomy System
The JETSTREAM Atherectomy System exhibited by Boston Scientific isThe Only One Approved in ChinaDebulking devices with active aspiration and plaque excision capabilities, which will"Three-in-one" forward rotary cutting tip, active suction system, and lateral expansion bladeCapable of grinding calcifications, excising plaques, and aspirating debris, while offering flexible treatment size options to maximize luminal gain.。
Boston Scientific JETSTREAM Atherectomy System
At the same time, Boston Scientific also showcased its products approved this year in the Chinese market.The FARAPULSE series of pulsed electric field ablation products have reportedly sold more than 1,400 units in China., and large-scale commercialization will be promoted next.
At the same time, there is alsoThe world's first FDA-approved coronary DCB product, AGENT Paclitaxel-Coated PTCA Balloon Catheter, and the SENTINEL Embolic Protection Device for TAVR (Transcatheter Aortic Valve Replacement), which has obtained triple certifications from CE, FDA, and NMPA.And many other innovative products.
Since its first participation in the CIIE in 2019,Boston Scientific has successfully transformed 21 innovative achievements from exhibits to commercial products., accelerating the launch in China. At this year's CIIE, in addition to the newExhibition outside,Boston Scientific will also join hands with representatives of local partners such as CinnoVas and NeoLight., jointly share the latest cooperative achievements, and explore an innovative win-win path of "In China, Benefit the World".
BD Medical
AsChairman Unit of the Medical Device Professional Committee of the CIIE Exhibition Alliance and a leading enterprise in the medical technology field, BD Medical has actively participated in the exhibition for many years, gaining widespread attention and acclaim for its demonstrated excellence in innovation and deep technical expertise.
This time, BD Medical appeared with the theme of "Excellence for Future Health," leading itsMore than 10 products on their China debutProducts and nearly a hundred already launched star products collectively appeared at the CIIE booth. The products coverPeripheral Interventions, Specialized Surgery, Oncology Diagnostics, Urology and Critical CareIn multiple fields such as...
First Look at New Products
World's First, China Launch: 3CG PICC Traceable and Locatable Peripherally Inserted Central Catheter
BD MedicalCustom-developed for the Chinese market, the 3CG PICC traceable and locatable peripherally inserted central catheter was launched ——The World's FirstA peripherally inserted central catheter with a passive magnetic support guidewire and an integrated guidewire lead design.
The innovative magnetic navigation technology equipped in this product enables full visualization during PICC catheter placement, making the process easier and more efficient for medical staff, thereby further enhancing the patient's infusion therapy experience.
At the same time, alsoCustomized for Chinese PatientsThe "Vascular Access Maintenance Record Mini Program" complements it, and together they can greatly help patients easily understand and successfully complete regular postoperative chemotherapy maintenance.
3CG PICC Traceable and Locatable Peripherally Inserted Central Catheter
ExceptThe venous catheter, targeting the Chinese market demand, BD also launched a high-end safety arterial blood collection device——BD PresetTM EclipseTM Flash Arterial Blood Sampler, this product has successfully entered multiple hospitals in China, as well as hospitals and third-party testing laboratories in China.First Limited Release of PAXgene® Whole Blood ccfDNA Preservation TubesAmong the eight new products. This series of cutting-edge innovative achievements aims to provide Chinese patients with more innovative, comprehensive, and diverse diagnosis and treatment solutions.
BD PresetTM EclipseTM Flash Arterial Blood Sampler
Global First, China Launch: Disposable Female Urinary Drainage Tray (PUREWICK® Female Urinary Catheter)
ThisAt this exhibition, BD Medical developedWorld's First, China LaunchThe Disposable Female Urinary Drainage Tray (PUREWICK® Female Urinary Collection System) also made a significant appearance at the BD Medical booth.
This product is dedicated to providing solutions for the approximately three million female patients in China each year who suffer from moderate to severe urinary incontinence or mobility issues requiring bedridden urination.Simple, Non-Invasive, and More Dignified Urination Solution.Improve the Quality of Care for Female Patients and Reduce Catheter-Associated Urinary Tract Infections.
Disposable Female Urinary Drainage Tray
Single-Use Female Urinary Catheter Kit (PUREWICK® Female Urinary Catheter)
Global Debut, Asian Debut, China Debut: BD FACSDiscover A8 Imaging Spectral Flow Cytometer
At the forefront of exploring digital and intelligent technologies, BD Medical also announced for the first time the launch ofGlobal Premiere, Asian Premiere, China PremiereThe BD FACSDiscover A8 Imaging Spectral Flow Cytometer.
As an advanced cell analysis instrument, it perfectly integrates spectral flow cytometry with imaging technology, and is hailed as"Spectral Flow Cytometer for Cell Visibility", ushering in a new chapter of visualization in flow technology. At the same time, this instrument can provide information on the physical and molecular characteristics of cells, enabling researchers to make breakthrough discoveries in a shorter period of time.
BD FACSDiscover A8 Imaging Spectral Flow Cytometer
Under the stars and moon, with the last ray of sunset, this commentator has concluded the coverage of the medical device exhibition area on the first day of the CIIE. From "first-time visitors" to "returning customers" and "permanent residents," multinational medical giants have truly showcased their full range of skills at the CIIE.Presenting the most cutting-edge and high-quality innovative black technologies one by one.At the CIIE, we can grasp the cutting-edge trends and innovative technologies of the global medical device industry. Focusing entirely on medical devices,"New Products, New Markets, New Technologies"Professional platform, Medical Device Business Review will continue to report, bringing you more on-site coverage!
The content of this article is for reference only and does not constitute investment advice. Readers are expected to effectively distinguish.If any platform reprints this article, it must take responsibility for the content of the article. Medical Device Business Review is not responsible for any impact caused by secondary dissemination after reprinting.
To ensure you don't miss any content, everyone remember toMedical Device Business ReviewSet as starred? Oh,
Looking forward to meeting you at the first moment every time
